Position in TECH
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$166,615,854
+$71,409,404 QoQ
Shares Held
3,188,210
+96.9% QoQ
Ownership
2.04%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TECH Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Capital Research Global Investors holds $13,789,933,930 across 16 Biotechnology names. TECH ranks #5 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
21,125,964 | $9,433,587,964 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
9,471,181 | $3,133,729,657 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
3,491,386 | $197,228,395 | |
| 4 | IDYA |
IDEAYA Biosciences, Inc.
|
5,163,543 | $172,049,252 | |
| 5 | TECH |
BIO-TECHNE Corp
This page
|
3,188,210 | $166,615,854 | |
| 6 | KYMR |
Kymera Therapeutics, Inc.
|
1,673,275 | $139,367,074 | |
| 7 | ADMA |
Adma Biologics, Inc.
|
11,191,116 | $100,831,955 | |
| 8 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,115,460 | $97,011,556 |
All Filings in TECH
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $166,615,854 | 3,188,210 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $95,206,450 | 1,618,882 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $90,426,676 | 1,625,502 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $51,756,127 | 1,005,950 | Shares | Defined | 2025-08-13 | |
| No filing history on record for this holder in this stock. | ||||||